Exactus Announces Agricultural Diversification with Entry Into 200-Acre Farming Project for 2019 Grow Season, Promotion of Emiliano Aloi as President

The company has acquired a majority interest in a 200-acre industrial hemp farm located in Cave Junction, Ore.

March 12, 2019

GLEN ALLEN, VA / GLOBE NEWSWIRE / March 11, 2019 / PRESS RELEASE / Exactus Inc., a healthcare company pursuing opportunities in hemp-derived cannabidiol (CBD) products, announced it has acquired a majority interest in a 200-acre industrial hemp farm located in Cave Junction, Ore. 

Philip J. Young, CEO of Exactus, stated: “We have developed a fully-integrated plan to own our own source of supply organized around our newly-formed majority owned subsidiary Exactus One World LLC. Exactus One World captures the essence of our spirit--to create a fully-integrated international leadership position promoting hemp based products. Cave Junction, Ore., is located in the Illinois Valley, well-known for its superior hemp growing topography. With the assistance of our experienced farming partners, Exactus One World has also been assured supply of superior seed genetics and has placed a large order for seed provided by Jack Hempicine, LLC. the highly-regarded Crawford Brothers hemp seed genetic stock company.”

To complete the transition to a fully-integrated company, Exactus also announced the appointment of Emiliano Aloi to the position of president. Aloi previously served as an advisor through Exactus’ largest shareholder, Ceed2Med. Aloi is a highly regarded farming, production and manufacturing expert who previously was the VP of strategic development at GenCanna Global, where he initiated a go-to strategy, recruited the commercial leadership team, developed compliance, executed product launches and advanced manufacturing in European markets. Aloi’s extensive industrial farming career experience also includes solid biofuel projects for Loma Negra alongside Nuseed and was instrumental in successfully achieving Uruguay’s first hemp license in March 2016.

Said Bobby Yampolsky, co-founder of Ceed2Med, “Since partnering with Exactus, we have felt that our support for their platform would lead to ever closer relations. To date, we have supported their growth through access to our people, experience, resources, contacts, and opportunities. We are thrilled to see this effort come to fruition around Exactus One World following introduction to our farming partners. We participated in negotiating this unique opportunity and are excited to support Exactus in acquiring one of our opportunities to farm in Oregon. We will continue to stay involved assisting Exactus to manage these and other opportunities. We also congratulate our co-founder Emiliano Aloi with his expected appointment as president of Exactus and will continue to support Aloi as the business of Exactus continues to evolve.”

Shea Mcinvale, Manager of Exactus One World also added, “We are pleased to partner with Exactus and are confident that together we will become a leader in the industry. Our previous success in producing these crops and our farming expertise makes us highly confident that we can provide Exactus One World with the highest quality product and superior yields. Using farming techniques we have developed over many years and our unique patent pending drying technology, we have embraced scientific principles we believe are able to maximize CBD concentration and biomass quality for successful production of crude. We look forward to maximizing the tremendous opportunity we have together.”

In the three months since entering the hemp-derived CBD marketplace, Exactus has succeeded in partnering with experienced producers, executed a supply and development agreement with Ceed2Med, acquired a majority stake in a highly desirable farm property, completed a first commercial sale of 750mg full spectrum advanced absorption tincture, and recapitalized with a greatly simplified capital structure.